Proposal

Novavax, a clinical stage vaccine company that is developing a COVID-19 vaccine, is requesting approval for two new R&D and manufacturing buildings totaling 604,929 gross square feet and an associated parking garage within a new campus environment.

Status

The Joint Public Hearing for SDP-9003-2021 was held on Monday, October 18, 2021. The Planning Commission record closes at 5 pm on Wednesday, November 10, 2021. The final staff recommendation will be ready on Friday, November 12, 2021 and the Planning Commission Recommendation will be presented on Wednesday, November 17, 2021 during the Planning Commission Meeting. The Mayor and City Council Record will close at 5 pm on Wednesday, November 24, 2021 with the anticipated Mayor and City Council Final Action to be presented on Monday, December 6, 2021 during the Mayor and City Council Meeting.

Previous Plan Approval

Z-7262-2016 - On July 18, 2016, the Mayor and City Council approved Zoning Map Amendment Application Z-7262-2016, Ordinance O-5-16, which includes the Subject Properties of this project. The approval resulted in the rezoning of approximately 15.38 acres from the C-2 (General Commercial) and E-1 (Urban Employment) zones to the MXD (Mixed Use Development) zone. The rezoning application was approved concurrently with Sketch Plan Z-7262-2021 for residential and mixed-use development.

SK-8813-2021 - On June 7, 2021, the Mayor and City Council approved Sketch Plan SK-8813-2021, R-26-21, for the development of 14 Firstfield Road. The Sketch Plan permits the property to be developed with up to seven stories and 604,929 square feet in multiple buildings. The Sketch Plan also increased the floor area ratio (FAR) from 0.75 to 1.5. FAR is the ratio of a building’s size to the land it sits on.

The Sketch Plan divides the property into three “Blocks.” The Subject application makes up Block 2.